Atlas Trials

A Clinical Study of the Value of Circulating Free Methylated EBV DNA in Extranodal NK/T Cell Lymphoma

Clinical trial NCT05343377 · NOT_YET_RECRUITING

Trial details

NCT number
NCT05343377
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Extranodal Natural Killer/T-cell Lymphoma
Start date
2022-06-01
Primary completion
2025-06-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.